trigram

This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

trigram	frequency
in patients with	1164
as well as	358
acute liver failure	355
of the liver	333
the presence of	316
of patients with	293
fatty liver disease	273
in the liver	260
the treatment of	245
the development of	213
chronic hepatitis b	206
patients with chronic	196
patients with liver	192
is associated with	190
chronic liver disease	187
dogs and cats	178
the use of	175
with chronic hepatitis	165
one of the	161
the most common	160
the effect of	155
nonalcoholic fatty liver	154
patients with severe	152
hepatitis b virus	147
in dogs and	147
chronic hepatitis c	146
a result of	143
in dogs with	137
of liver injury	133
the diagnosis of	133
patients with cirrhosis	132
hepatitis c virus	127
as a result	126
fulminant hepatic failure	126
in cats with	126
the incidence of	123
patients with acute	123
relationships to disclose	122
in the treatment	122
no relationships to	122
the risk of	120
patients with covid	117
liver injury in	115
in addition to	114
the number of	113
of liver disease	113
the role of	113
of liver failure	113
because of the	112
the severity of	109
of hepatitis b	108
alcoholic fatty liver	108
in this study	106
in order to	106
chronic liver failure	106
for patients with	105
the degree of	102
the expression of	101
with liver disease	101
of chronic hepatitis	100
the portal vein	99
there was no	99
a total of	98
due to the	98
for the treatment	98
can be used	97
it has been	95
is the most	94
based on the	93
has not been	92
has been reported	91
in the dog	90
of this study	90
the liver is	90
be associated with	90
associated with the	90
of acute liver	89
there is no	89
induced liver injury	89
the time of	88
liver disease in	88
after liver transplantation	88
this study was	87
role in the	87
the pathogenesis of	86
of the disease	86
should be considered	86
risk factors for	86
the aim of	84
p r o	84
r o o	84
o o f	84
l p r	84
n a l	84
r n a	84
u r n	84
cod liver oil	84
j o u	84
o u r	84
a l p	84
p r e	84
an increase in	83
according to the	83
to evaluate the	82
a variety of	82
in the presence	82
in the united	81
of hepatic encephalopathy	81
there is a	81
the united states	80
the absence of	80
at the time	79
study was to	79
liver disease and	77
the level of	76
with acute liver	76
to be a	75
with severe hepatitis	75
is important to	74
it is important	74
in the cat	74
was associated with	73
the patients with	71
be used to	71
a number of	70
mesenchymal stem cells	69
with or without	69
related to the	69
an important role	68
of chronic liver	68
the management of	68
in acute liver	67
the present study	67
the liver and	67
to determine the	66
the end of	66
of the patients	66
for the diagnosis	66
the effects of	65
may not be	65
cd t cells	65
the course of	65
appears to be	65
of liver function	64
can lead to	64
with liver cirrhosis	64
to investigate the	63
have been reported	63
is an important	63
for treatment of	63
in a cat	62
important role in	62
been shown to	62
critically ill patients	62
liver transplantation in	62
stage liver disease	62
is one of	61
the majority of	61
may lead to	61
clinical characteristics of	61
in combination with	61
log copies ml	61
involved in the	61
more likely to	61
and treatment of	61
to assess the	60
to the liver	60
of liver fibrosis	60
the other hand	59
found to be	59
can also be	59
the prevalence of	59
part of the	58
on the other	58
are associated with	58
with chronic liver	58
aim of this	58
considered to be	58
associated with a	58
the levels of	58
of liver diseases	57
the basis of	57
the efficacy of	57
were treated with	57
the formation of	57
liver failure in	57
the relationship between	57
spontaneous bacterial peritonitis	57
as compared to	57
to be the	56
the rate of	56
compared to the	56
clinical signs of	56
may also be	56
in the absence	55
been reported in	55
orthotopic liver transplantation	55
of hepatocellular carcinoma	54
there was a	54
the cause of	54
should be performed	53
has also been	53
is caused by	53
of cats with	52
in the early	52
has been shown	52
risk factor for	51
a decrease in	51
was used to	51
in these patients	51
in one study	51
the liver in	51
it should be	51
the occurrence of	51
the mechanism of	50
of the portal	50
with liver injury	50
cells in the	50
hepatic stellate cells	50
the most important	50
at the end	49
of liver transplantation	49
in a dog	49
the production of	49
may be a	49
changes in the	49
of portal hypertension	49
in chronic hepatitis	49
is characterized by	48
for liver transplantation	48
been reported to	48
patients with nonalcoholic	48
patients with a	47
of the hepatic	47
should not be	47
liver injury and	47
on the basis	47
than that of	47
the results of	47
chronic liver diseases	47
acute and chronic	46
the two groups	46
reported to be	46
in the pathogenesis	46
in the development	46
is a common	46
with nonalcoholic fatty	45
be caused by	45
of these patients	45
to mg kg	45
may be present	45
can result in	45
acute liver injury	45
was observed in	45
inflammatory bowel disease	45
in response to	45
significantly higher in	44
was found to	44
hepatic encephalopathy in	44
in some cases	44
a combination of	44
of the most	44
liver injury was	43
was significantly higher	43
likely to be	43
the need for	43
which may be	43
the study of	43
the amount of	43
have shown that	43
between the two	43
patients with hepatitis	43
liver fibrosis in	43
appear to be	42
a role in	42
have been described	42
hepatitis b patients	42
the impact of	42
portosystemic shunts in	42
in liver transplantation	42
systemic inflammatory response	42
evaluation of the	42
hbv dna levels	41
well as the	41
patients infected with	41
during the first	41
been associated with	41
in cirrhotic patients	41
has been suggested	41
and in the	41
by the liver	41
and can be	41
patients with advanced	40
liver failure and	40
increase in the	40
have not been	40
it can be	40
the result of	40
the small intestine	40
of the study	40
in both groups	40
compared with the	40
in cases of	40
in the first	40
a systematic review	40
common bile duct	40
there are no	40
patients with alf	40
it may be	40
used as a	40
small cell lymphoma	40
may result in	39
in severe hepatitis	39
in the study	39
be related to	39
of severe hepatitis	39
showed that the	39
liver function tests	39
liver transplantation for	39
be used as	39
serum hbv dna	39
a history of	39
the frequency of	39
of vitamin a	39
there were no	38
is similar to	38
of nonalcoholic fatty	38
no significant difference	38
it is also	38
and safety of	38
patients with hcc	38
may be associated	38
liver transplant recipients	38
intensive care unit	38
the proportion of	38
patients treated with	38
it is not	38
the activity of	38
caused by a	38
hepatitis b and	38
the gastrointestinal tract	38
quality of life	37
the underlying cause	37
the progression of	37
and it is	37
cd t cell	37
patients with type	37
depending on the	37
and may be	37
in fulminant hepatic	37
play an important	37
need to be	37
with liver failure	37
play a role	37
clinical features of	37
treatment of liver	37
of dogs with	36
in most cases	36
is based on	36
polymerase chain reaction	36
has been described	36
liver disease is	36
the systemic circulation	36
higher than that	36
may be used	36
in lc patients	36
most of the	36
in some patients	36
is difficult to	36
in the patients	36
found in the	36
efficacy and safety	36
respiratory distress syndrome	36
and should be	36
disease in dogs	35
a patient with	35
more common in	35
a series of	35
the control group	35
among patients with	35
serum alt activity	35
a retrospective study	35
significantly higher than	35
the administration of	35
t cell responses	35
and the liver	35
factors associated with	35
patients in the	35
the possibility of	35
the ability to	35
injury in covid	35
before and after	34
with hepatitis b	34
liver failure is	34
severe acute respiratory	34
that can be	34
was defined as	34
the size of	34
other causes of	34
the combination of	34
caudal vena cava	34
liver cirrhosis and	34
contribute to the	34
patients with fulminant	34
acute exacerbation of	34
upper limit of	34
a consequence of	34
with cirrhosis and	34
was found in	34
were used to	33
the concentration of	33
in critically ill	33
chronic hbv infection	33
but it is	33
cirrhotic patients with	33
and cats with	33
up to of	33
sensitivity and specificity	33
at the same	33
to study the	33
significant difference in	33
pneumonia in wuhan	33
disease in the	33
been described in	33
to have a	33
should be used	33
analysis of the	33
for more than	33
of hepatic fibrosis	33
such as the	33
associated with increased	33
are the most	33
patients with decompensated	33
systematic review and	33
a review of	33
than that in	33
patients with hbv	33
in the case	32
patients with non	32
with a high	32
chronic hepatitis and	32
to reduce the	32
is related to	32
associated liver injury	32
liver transplantation is	32
the case of	32
of liver damage	32
the pathophysiology of	32
in the blood	32
to that of	32
similar to that	32
in the diagnosis	32
can be found	32
alt and ast	31
serum levels of	31
study of the	31
which can be	31
has been used	31
due to a	31
a risk factor	31
abnormal liver function	31
is thought to	31
disseminated intravascular coagulation	31
fulminant liver failure	31
of clinical signs	31
acute respiratory syndrome	31
not associated with	31
divided into two	31
the metabolism of	31
included in the	31
in those with	31
in the present	31
increased risk of	31
caused by the	30
the influence of	30
serum bile acids	30
review and meta	30
inflammatory response syndrome	30
were divided into	30
the onset of	30
the clinical signs	30
tumor necrosis factor	30
by flow cytometry	30
severe hepatitis b	30
alcoholic liver disease	30
this is a	30
effect of the	30
were significantly higher	30
the regulation of	30
chronic hepatitis in	30
after cardiac death	30
of the patient	30
of cases of	30
in the portal	30
common cause of	30
is considered to	30
size of the	30
the activation of	30
a dose of	30
the patient is	30
liver injury is	30
morbidity and mortality	30
in the control	30
are more likely	30
in contrast to	30
aim of the	29
from patients with	29
g dry weight	29
mg kg day	29
in group a	29
in the same	29
severity of liver	29
in chronic liver	29
in hepatocellular carcinoma	29
be considered as	29
the fact that	29
mild to moderate	29
acute respiratory distress	29
be divided into	29
may be the	29
to the development	29
should be avoided	29
shown to be	29
and management of	29
shunts in dogs	29
diseases of the	29
the diagnosis and	29
the increase in	29
decrease in the	29
in liver transplant	29
in patients who	29
body mass index	29
because of its	29
the early stage	29
and hepatocellular carcinoma	29
the prevention of	28
of the gallbladder	28
treatment of chronic	28
dogs with chronic	28
b and c	28
of acute hepatitis	28
injury in patients	28
for the study	28
for the development	28
diagnosis and treatment	28
can be considered	28
be considered in	28
responsible for the	28
limit of normal	28
the same time	28
liver damage in	28
addition to the	28
a recent study	28
used in the	28
at increased risk	28
specific cd t	28
disease in cats	28
and chronic liver	28
in a study	28
in of the	28
of mg kg	28
were found to	28
we found that	28
that patients with	28
than those in	28
mg kg po	28
have been used	28
results suggest that	28
is also a	28
in liver disease	28
were associated with	28
results of a	28
were found in	27
than in the	27
for at least	27
use of a	27
be seen in	27
be due to	27
dog and cat	27
in all patients	27
with and without	27
minimal hepatic encephalopathy	27
studies have shown	27
donation after cardiac	27
if there is	27
in a patient	27
in patients undergoing	27
of patients in	27
some of the	27
with portal hypertension	27
factors such as	27
of the virus	27
of the small	27
with hepatic lipidosis	27
be used for	27
reactive oxygen species	27
clinical signs and	27
kg body weight	27
with hepatocellular carcinoma	27
of liver tissue	27
nature of the	27
hepatitis and cirrhosis	27
the dog and	27
a cat with	27
on the liver	27
in liver cirrhosis	27
when compared with	27
early stage of	27
clinical signs are	27
for the first	27
derived mesenchymal stem	27
lead to the	27
was no significant	27
oxidative stress and	27
months of age	27
traditional chinese medicine	26
the upper limit	26
large number of	26
for cats with	26
should be given	26
may be useful	26
cats with hepatic	26
can be divided	26
were observed in	26
severe hepatitis patients	26
the detection of	26
to determine whether	26
portal hypertension and	26
for acute liver	26
the synthesis of	26
may be beneficial	26
similar to those	26
transforming growth factor	26
during liver transplantation	26
the bile ducts	26
a reduction in	26
is used to	26
years of age	26
patients with hepatic	26
used for the	26
course of the	26
with novel coronavirus	26
in liver failure	26
the function of	26
increases in serum	26
the normal range	26
the ability of	26
consistent with the	26
congenital portosystemic shunts	25
reduction in the	25
hepatic blood flow	25
as a consequence	25
most common cause	25
because of their	25
is involved in	25
the cat is	25
a study of	25
chronic hcv infection	25
be treated with	25
canine and feline	25
associated with liver	25
patients with he	25
the ratio of	25
puppies and kittens	25
in another study	25
of more than	25
patients with nafld	25
fibrosis in patients	25
liver transplant patients	25
liver enzyme activity	25
of hepatitis c	25
in the management	25
thought to be	25
should also be	25
of patients were	25
should be noted	25
dose of mg	25
is not a	25
number of patients	25
the most commonly	25
and liver failure	25
for chronic hepatitis	25
correlated with the	25
are involved in	25
at risk for	24
of nonalcoholic steatohepatitis	24
the etiology of	24
liver function in	24
the assessment of	24
to be an	24
did not have	24
feline infectious peritonitis	24
to be associated	24
bile duct obstruction	24
when compared to	24
the abdominal cavity	24
plays an important	24
role of the	24
the prognosis of	24
portal vein thrombosis	24
in association with	24
more than of	24
was seen in	24
resulted in a	24
the release of	24
for diagnosis of	24
assessment of the	24
with fulminant hepatic	24
is common in	24
the length of	24
type diabetes mellitus	24
b virus infection	24
total of patients	24
in terms of	24
and severity of	24
severe liver disease	24
chain amino acids	24
a prospective study	24
multiple organ failure	24
a group of	24
randomized controlled trial	24
of patients infected	24
also known as	24
in of patients	24
the importance of	24
the hepatic parenchyma	24
expression of the	24
severity of the	24
the purpose of	23
study showed that	23
and portal vein	23
in bedlington terriers	23
significantly associated with	23
be useful in	23
if the patient	23
the study was	23
in which the	23
of the pancreas	23
seems to be	23
difference in the	23
hepatocellular carcinoma in	23
present in the	23
with hepatic encephalopathy	23
may play a	23
as compared with	23
and development of	23
of novel coronavirus	23
at least one	23
been suggested that	23
significantly increased in	23
transjugular intrahepatic portosystemic	23
in recent years	23
ill patients with	23
activation of the	23
was performed in	23
with severe liver	23
the most frequent	23
patients with ascites	23
to confirm the	23
of patients who	23
of portosystemic shunting	23
of liver cirrhosis	23
found that the	23
was determined by	23
be found in	23
risk of developing	23
in cats is	23
a diagnosis of	23
and patients with	23
no evidence of	23
important to note	23
serum alp activity	23
and prognosis of	23
elevated liver enzymes	23
levels of serum	23
the lack of	23
were subjected to	23
liver function and	23
to determine if	23
hbv dna level	23
the intestinal tract	23
as part of	23
for liver injury	23
the caudal vena	23
in conjunction with	23
is believed to	23
observed in the	23
shown in table	23
may be seen	22
to examine the	22
patients with chb	22
associated with hepatic	22
at risk of	22
this study is	22
was higher in	22
have also been	22
and so on	22
can occur in	22
no significant differences	22
remains to be	22
respiratory syndrome coronavirus	22
in the body	22
blood flow and	22
west highland white	22
in the course	22
is the only	22
in neonatal foals	22
of coronavirus disease	22
smooth muscle actin	22
closely related to	22
prevention and treatment	22
donor liver transplantation	22
intestinal epithelial cells	22
seen in the	22
for the prevention	22
in clinical practice	22
referred to as	22
liver and kidney	22
living donor liver	22
be used in	22
infected with hcv	22
the stage of	22
the outcome of	22
significant differences in	22
portal blood flow	22
patients who underwent	22
in treatment of	22
hepatitis b surface	22
lower than that	22
was a significant	22
liver failure patients	22
can be associated	22
patients were treated	22
function of the	22
a large number	22
the early stages	22
to explore the	22
significantly regulated proteins	22
is more common	22
the liver may	22
the process of	22
the potential to	22
model for end	22
elevated levels of	21
needs to be	21
who did not	21
divided into three	21
within the liver	21
group of patients	21
a poor prognosis	21
can be a	21
the university of	21
lead to a	21
as high as	21
to note that	21
has been associated	21
bile acid concentrations	21
factors for liver	21
a cause of	21
of hbv infection	21
end of the	21
failure caused by	21
clinical manifestations of	21
present study was	21
was carried out	21
the efficacy and	21
the sensitivity of	21
inflammation and fibrosis	21
of liver cells	21
the anhepatic stage	21
understanding of the	21
of the clinical	21
we aimed to	21
in the hepatic	21
characterized by the	21
the common bile	21
of the biliary	21
with type diabetes	21
a liver biopsy	21
may be related	21
were included in	21
was used for	21
and hepatitis c	21
degree of liver	21
with hepatitis c	21
exacerbation of hepatitis	21
with the exception	21
cells of the	21
it is difficult	21
should be taken	21
depends on the	21
with respect to	21
disease regulated proteins	21
increased risk for	21
with chronic hcv	21
existing liver disease	21
all patients were	21
may occur in	21
should be treated	21
may contribute to	21
which is a	21
to compare the	21
may have a	21
to identify the	21
majority of patients	21
central nervous system	21
the association of	20
the reduction of	20
in a large	20
in nonalcoholic fatty	20
the exception of	20
of the body	20
leading to the	20
are shown in	20
association for the	20
with decompensated cirrhosis	20
novel coronavirus pneumonia	20
but not in	20
was reported to	20
controlled trial of	20
these results suggest	20
hcv core protein	20
should be administered	20
markers of liver	20
is a major	20
so that the	20
the existence of	20
higher in the	20
occur as a	20
reported that the	20
well as in	20
patients with hepatocellular	20
as a cause	20
b surface antigen	20
result of the	20
was measured by	20
is defined as	20
the pattern of	20
of the intestinal	20
of the first	20
were determined by	20
prior to the	20
of the gastrointestinal	20
is due to	20
liver fibrosis and	20
reperfusion injury in	20
a descriptive study	20
disorders of the	20
correlation between the	20
in our study	20
cause of chronic	20
at a dose	20
with regard to	20
is consistent with	20
the risk factors	20
of the underlying	20
the hypothesis that	20
and has been	20
associated with an	20
linear foreign bodies	20
was higher than	20
the liver of	20
activity of the	20
may be required	20
likely to have	20
physical examination findings	20
treatment of hepatic	20
study is to	20
in vitro and	20
liver biopsy is	20
the site of	20
in relation to	20
a and b	20
the percentage of	20
patients with pre	20
there are several	20
male and female	20
to rule out	20
of liver cell	20
of the present	20
the nature of	20
the prevention and	20
of the following	20
in many cases	20
it is possible	20
can be seen	20
none of the	20
for detection of	20
higher than those	20
at the level	20
associated with acute	19
be performed in	19
mrna and protein	19
as assessed by	19
of abdominal pain	19
have been identified	19
epidermal growth factor	19
acute kidney injury	19
cats with chronic	19
end of treatment	19
patients who had	19
and liver disease	19
characteristics of cases	19
common in cats	19
may be more	19
for the detection	19
be involved in	19
were measured by	19
to patients with	19
complications such as	19
patients who were	19
and risk factors	19
resulting in a	19
hepatic encephalopathy and	19
significant increase in	19
after partial hepatectomy	19
clinical characteristics and	19
all of the	19
cause of the	19
in the serum	19
to of the	19
dogs with hepatic	19
in young dogs	19
for use in	19
the immune response	19
into two groups	19
times the upper	19
was to evaluate	19
kg po q	19
be noted that	19
in liver fibrosis	19
the mean age	19
hepatic fibrosis and	19
can be performed	19
patients with normal	19
by the presence	19
the probability of	19
effect on the	19
small amount of	19
in the two	19
advanced liver disease	19
different stages of	19
with a mean	19
a novel coronavirus	19
that of the	19
study was conducted	19
effects of the	19
increased levels of	19
more than years	19
serum level of	19
of the cases	19
compared with those	19
a definitive diagnosis	19
and outcomes of	19
acute hepatitis b	19
the induction of	19
as soon as	19
the proliferation of	19
to predict the	19
the liver has	19
oral administration of	19
liver is the	19
could not be	19
to increase the	19
in cats and	19
high levels of	19
patients with primary	19
in liver tissue	19
serum bile acid	19
is required for	19
was detected in	19
the loss of	19
this article is	19
suggest that the	19
of the stomach	18
by means of	18
the liver function	18
in chb patients	18
following liver transplantation	18
should be evaluated	18
the evaluation of	18
of the abdomen	18
is needed to	18
patients with genotype	18
of liver biopsy	18
acute or chronic	18
causes of diarrhea	18
intrahepatic portosystemic shunt	18
analysis showed that	18
than those without	18
the growth of	18
with signs of	18
hepatitis in dogs	18
after weeks of	18
reported in cats	18
review of the	18
the novel coronavirus	18
be ruled out	18
of cod liver	18
the peripheral blood	18
it is a	18
is more likely	18
vascular endothelial growth	18
in liver diseases	18
with the use	18
used as an	18
the potential for	18
found in patients	18
believed to be	18
patients and methods	18
increase the risk	18
the extent of	18
liver failure are	18
genes involved in	18
in patients without	18
in comparison to	18
treatment of acute	18
into the systemic	18
in the rat	18
was present in	18
in the literature	18
not appear to	18
cats with liver	18
in most patients	18
during the course	18
levels in patients	18
used to treat	18
and liver biopsy	18
patients with high	18
chronic severe hepatitis	18
is the first	18
significant decrease in	18
in a dose	18
patients with lc	18
portal hypertension is	18
hospitalized patients with	18
the innate immune	18
management of acute	18
wide range of	18
considered as a	18
as shown in	18
the immune system	18
sinusoidal endothelial cells	18
and in vivo	18
proportion of patients	18
survival in patients	18
in the majority	18
intrahepatic bile ducts	18
an indicator of	18
during the covid	18
the form of	18
acute liver disease	18
liver diseases in	18
treatment of the	18
commonly associated with	18
regardless of the	18
it does not	18
hbv and hcv	18
all patients with	18
a significant increase	18
result of a	18
hepatocyte growth factor	18
no difference in	18
did not differ	17
several studies have	17
were randomized to	17
po q h	17
that has been	17
high fat diet	17
patients with the	17
increase in serum	17
may be an	17
in hepatic encephalopathy	17
acute hepatic necrosis	17
a randomized controlled	17
infection in patients	17
is less than	17
low cardiac output	17
those patients with	17
of which are	17
vitro and in	17
the addition of	17
treatment should be	17
patients with alcoholic	17
the inhibition of	17
high mortality rate	17
of kupffer cells	17
was performed on	17
of patients had	17
patients with cld	17
safety and efficacy	17
of coagulation factors	17
capacity of the	17
ischemia reperfusion injury	17
determined by the	17
study of liver	17
been used in	17
materials and methods	17
liver disease can	17
of spontaneous bacterial	17
to chronic hepatitis	17
the liver was	17
in the s	17
and portal hypertension	17
hepatobiliary disease in	17
no effect on	17
in group b	17
failure due to	17
it was reported	17
due to its	17
of amino acids	17
the neonatal foal	17
days after the	17
for liver disease	17
the source of	17
and insulin resistance	17
cirrhosis and hepatocellular	17
endothelial growth factor	17
were higher in	17
that there is	17
signs of he	17
is responsible for	17
of the therapy	17
acute hepatic failure	17
t cells in	17
the bone marrow	17
with acute hepatitis	17
world health organization	17
analysis was performed	17
sustained virologic response	17
a major role	17
and clinical characteristics	17
that in the	17
patients with hbeag	17
the peritoneal cavity	17
of fulminant hepatic	17
liver fat content	17
this is the	17
the general population	17
international normalized ratio	17
this can be	17
the liver can	17
to be more	17
retrospective study of	17
a mean of	17
the liver tissue	17
and those with	17
of hbv dna	17
in doberman pinschers	17
obstruction of the	17
infection in a	17
hepatic fibrosis in	17
of nk cells	17
resulting in the	17
liver failure caused	17
can be identified	17
in the prevention	17
and weight loss	17
is known to	17
with the severity	17
with severe covid	17
acute hepatitis and	17
we investigated the	17
be the most	17
the accumulation of	17
increased expression of	17
was to investigate	17
patients should be	17
occur in the	17
different types of	17
the critically ill	17
positively correlated with	17
shortness of breath	17
hepatitis b e	17
in hepatitis b	17
and the presence	17
factor in the	17
proton pump inhibitors	17
of hepatobiliary disease	17
nitric oxide synthase	17
the prognosis is	17
is the major	17
are needed to	17
diagnosis and management	17
in case of	17
varying degrees of	16
it is the	16
be beneficial in	16
patients undergoing liver	16
significant reduction in	16
out of patients	16
patients with hcv	16
defined as the	16
may present with	16
in severe covid	16
retrospective analysis of	16
in the clinical	16
hepatitis c patients	16
was shown to	16
examination of the	16
red blood cells	16
for development of	16
the bile duct	16
the type of	16
human hepatocellular carcinoma	16
the increase of	16
mechanism of action	16
and liver fibrosis	16
a significant decrease	16
ast and alt	16
of viral hepatitis	16
cell proliferation and	16
expression level of	16
chronic liver insufficiency	16
in the intestine	16
the measurement of	16
and the risk	16
the association between	16
peripheral blood mononuclear	16
with nonalcoholic steatohepatitis	16
in the form	16
is the main	16
symptoms such as	16
lower in the	16
logistic regression analysis	16
were detected in	16
of hcv rna	16
were carried out	16
in the intestinal	16
a wide range	16
severity of hepatic	16
may be caused	16
the characteristics of	16
regulatory t cells	16
the context of	16
chronic active hepatitis	16
increased in patients	16
seen in patients	16
the liver injury	16
and hepatic encephalopathy	16
we have previously	16
for liver fibrosis	16
was positive in	16
and hbv dna	16
increased liver enzyme	16
and duration of	16
the surface of	16
the intestinal mucosa	16
undergoing liver transplantation	16
of mesenchymal stem	16
not have a	16
is not recommended	16
of inflammation and	16
be able to	16
of liver dysfunction	16
used to detect	16
the prognosis for	16
in the past	16
liver cell damage	16
in the brain	16
after circulatory death	16
a minimum of	16
in cases with	16
in those patients	16
of liver transplant	16
the duration of	16
associated with severe	16
mean age of	16
is known about	16
positive chronic hepatitis	16
of the bile	16
patients with mild	16
a small amount	16
based on clinical	16
comparison of the	16
most cats with	16
leads to the	16
regulated proteins were	16
for the presence	16
can be caused	16
a marker of	16
cats with diarrhea	16
preexisting liver disease	16
was evaluated by	16
are consistent with	16
had significantly higher	16
glomerular filtration rate	16
the hepatic artery	16
a period of	16
risk of liver	16
of the graft	16
of hcv infection	16
a significant reduction	16
large amount of	16
should be done	16
into the liver	16
in this chapter	16
development of hepatic	16
the setting of	16
was designed to	16
with hbv dna	16
have demonstrated that	16
and the number	16
primary liver disease	16
of the blood	16
in the neonatal	16
is essential for	16
epidemiological and clinical	16
as long as	16
of hospital stay	16
compared to those	16
little is known	16
treatment of patients	16
if the cat	16
in the setting	16
may be due	16
be difficult to	16
to respond to	16
underlying liver disease	16
during the anhepatic	16
signs and symptoms	16
there have been	15
the liver are	15
period of time	15
to be at	15
reported in the	15
detected in the	15
is reported to	15
more than one	15
development of the	15
of up to	15
acute renal failure	15
an important factor	15
use of these	15
of the abdominal	15
in a liver	15
this study were	15
hepatic abscesses in	15
liver biopsy specimens	15
mitochondria isolated from	15
of the major	15
in serum alt	15
hcv rna was	15
vitamin a and	15
systemic vascular resistance	15
cause liver damage	15
to an increase	15
of fatty liver	15
of severe covid	15
is required to	15
t cells were	15
response to treatment	15
associated liver disease	15
severe hepatitis is	15
inflammatory liver disease	15
the biliary tract	15
described in the	15
any of the	15
in the group	15
moderate to severe	15
hepatic copper concentrations	15
even in the	15
critically ill and	15
of bile acids	15
in one case	15
to decrease the	15
there is an	15
is protected by	15
with hbv infection	15
liver injury during	15
vitamin a supplementation	15
a report of	15
were more likely	15
in peripheral blood	15
transplantation for acute	15
blood ammonia concentration	15
of liver enzymes	15
high level of	15
the first time	15
patients had a	15
this may be	15
independent risk factor	15
assessment of liver	15
hcv infected patients	15
combination therapy of	15
demonstrated that the	15
can also occur	15
safe and effective	15
are more common	15
studies showed that	15
major role in	15
damage to the	15
higher risk of	15
the liver cells	15
a case of	15
in patients treated	15
used to assess	15
found to have	15
were enrolled in	15
there are many	15
in nafld patients	15
the gi tract	15
that leads to	15
development of liver	15
an increased risk	15
prospective study of	15
the underlying disease	15
is a key	15
exacerbation of chronic	15
steatosis and fibrosis	15
to be effective	15
as a potential	15
the improvement of	15
suggested that the	15
blood mononuclear cells	15
as it is	15
that have been	15
to play a	15
and dietary supplements	15
and chronic hepatitis	15
the liver transplant	15
removal of the	15
they are not	15
was the most	15
therapy should be	15
hepatic necrosis and	15
function in patients	15
in cats are	15
showed a significant	15
in the future	15
liver transplantation and	15
and liver injury	15
the change of	15
small number of	15
and mortality in	15
side effects of	15
management of patients	15
liver disease a	15
was confirmed by	15
herbal and dietary	15
in a recent	15
are difficult to	15
of the colon	15
most commonly used	15
was reported that	15
treatment of choice	15
with an increased	15
with hepatic disease	15
of at least	15
of this disease	15
differences in the	15
and in patients	15
of alt and	15
of vitamin d	15
of less than	15
were obtained from	15
extrahepatic bile duct	15
central venous pressure	15
is necessary for	15
in animals with	15
do not have	15
in the normal	15
is a rare	15
on chronic liver	15
clinical and biochemical	15
of oxidative stress	15
are known to	15
to of cases	15
have been shown	15
are similar to	15
is not clear	15
of nitric oxide	15
mesenteric lymph nodes	15
may be helpful	15
liver disease patients	15
as in the	15
in liver function	15
portal vein and	15
is determined by	15
is likely to	15
to days after	15
produced by the	15
in children with	15
of the dog	15
soon as possible	15
with t dm	14
the survival rate	14
and the development	14
risk factors of	14
in the number	14
have to be	14
definitive diagnosis of	14
sustained virological response	14
to the severity	14
to clarify the	14
only in the	14
are at risk	14
not specific for	14
from the liver	14
with the development	14
has been proposed	14
that liver injury	14
of acute and	14
the beginning of	14
of age and	14
in to of	14
we conclude that	14
aromatic amino acids	14
chronic liver injury	14
article is protected	14
protected by copyright	14
cd and cd	14
and use of	14
of the intrahepatic	14
more frequent in	14
exocrine pancreatic insufficiency	14
portosystemic shunting in	14
the identification of	14
been used to	14
and feline liver	14
the action of	14
ischemia and reperfusion	14
a lack of	14
were positive for	14
study of cases	14
the analysis of	14
alp and ggt	14
all rights reserved	14
is the primary	14
acute cellular rejection	14
been identified in	14
for hepatocellular carcinoma	14
in the stomach	14
combination treatment of	14
can be detected	14
been reported that	14
in up to	14
may result from	14
observed that the	14
of liver regeneration	14
liver failure with	14
the three groups	14
should be monitored	14
with congenital pss	14
evidence of hepatic	14
in the non	14
and characterization of	14
and risk of	14
blood samples were	14
the copyright holder	14
diagnostic value of	14
and activation of	14
in humans with	14
serum alanine aminotransferase	14
transplantation in the	14
leads to a	14
can be made	14
in a foal	14
half of the	14
cardiac output and	14
of the total	14
changes in liver	14
the goal of	14
in of cats	14
because it is	14
amino acids and	14
significant improvement in	14
or in the	14
expression of tlr	14
a retrospective analysis	14
patients were enrolled	14
purpose of this	14
on liver biopsy	14
of the immune	14
results in a	14
all cats with	14
of the cell	14
the serum level	14
and oxidative stress	14
there has been	14
in rats with	14
hepatic encephalopathy is	14
should always be	14
patients with portal	14
not be used	14
if they are	14
between patients with	14
especially in patients	14
of portosystemic shunts	14
dogs with congenital	14
coronavirus pneumonia in	14
hepatic injury in	14
the survival of	14
cd l mab	14
survival of patients	14
hepatitis e virus	14
which has been	14
and the other	14
be a result	14
portion of the	14
group a and	14
with clinical signs	14
it appears that	14
with the degree	14
levels in the	14
results in the	14
therapy for the	14
were compared with	14
to occur in	14
of the common	14
recent studies have	14
activation of coagulation	14
of chronic hbv	14
the secretion of	14
mesenchymal stem cell	14
hepatic copper accumulation	14
and platelet count	14
of a new	14
and clinical outcomes	14
strongly associated with	14
as a marker	14
be classified as	14
gene expression in	14
measurement of serum	14
study was designed	14
in the process	14
incidence of liver	14
hepatic copper content	14
combination therapy with	14
mg kg iv	14
which leads to	14
c virus infection	14
gene expression of	14
blood from the	14
associated with chronic	14
highland white terriers	14
in a mouse	14
be given to	14
in the last	14
the response to	14
response to therapy	14
of the two	14
as measured by	14
is a very	14
should be carefully	14
in liver injury	14
lobular dissecting hepatitis	14
with advanced liver	14
with acute hepatic	14
expression in the	14
less than of	14
was performed using	14
the initiation of	14
higher than the	14
to improve the	14
data suggest that	14
of congenital portosystemic	14
independent risk factors	14
led to the	14
the study period	14
hepatic stellate cell	14
this test is	14
b patients with	14
and does not	14
length of stay	14
disease in china	14
encephalopathy in patients	14
and liver function	14
complications of liver	14
of the treatment	14
of serum hbv	14
diagnosis is made	14
ace expression in	13
bile acids in	13
findings in dogs	13
the patients were	13
factor for the	13
neutrophil extracellular traps	13
during the treatment	13
acute hepatitis c	13
not been reported	13
in some cats	13
is accompanied by	13
of the presence	13
of the cat	13
and renal failure	13
data were collected	13
for the management	13
that in patients	13
is necessary to	13
the first weeks	13
in of cases	13
is indicated in	13
are not specific	13
in the context	13
hepatic steatosis and	13
effects on the	13
similar to the	13
role in liver	13
be helpful in	13
an independent risk	13
in spite of	13
derived from the	13
were present in	13
of death in	13
the control of	13
some patients with	13
patients were included	13
participate in the	13
histologic evidence of	13
after the first	13
in humans and	13
is present in	13
were no significant	13
in clinical trials	13
the effectiveness of	13
cases of novel	13
of hepatorenal syndrome	13
chronic viral hepatitis	13
increased serum alt	13
definitive diagnosis is	13
injury in the	13
into three groups	13
patients with hps	13
blood flow in	13
with dcd lt	13
of peripheral blood	13
was no difference	13
not significantly different	13
advanced liver fibrosis	13
and function of	13
a majority of	13
location of the	13
of these cells	13
patients who have	13
procent van de	13
novel coronavirus in	13
that there was	13
natural history of	13
stage of liver	13
was detected by	13
and outcome of	13
and is associated	13
can be achieved	13
and after the	13
in puppies and	13
serve as a	13
for up to	13
interferon and ribavirin	13
it is very	13
disease in a	13
should be started	13
fatty liver diseases	13
levels were significantly	13
seem to be	13
in more than	13
of disease progression	13
be one of	13
body weight ratio	13
leading to a	13
of hepatic stellate	13
and there is	13
is recommended to	13
suggested to be	13
management and challenges	13
or may not	13
be taken to	13
such as those	13
the changes in	13
lower esophageal sphincter	13
may or may	13
of hepatic function	13
the intensive care	13
of hepatic failure	13
the dynamic changes	13
of hepatic steatosis	13
in all cases	13
high viral load	13
is an effective	13
from the portal	13
concentrations in the	13
in the late	13
linear foreign body	13
disease may be	13
of intracranial pressure	13
diagnosis of canine	13
be present in	13
when there is	13
pulmonary vascular dilatation	13
th and th	13
significant difference between	13
those with a	13
for hepatitis b	13
viral load and	13
an important cause	13
hepatic venous pressure	13
data from the	13
to test the	13
important cause of	13
should be suspected	13
included in this	13
there may be	13
a large amount	13
relationship between the	13
significantly different between	13
performed in patients	13
by administration of	13
compared with other	13
blood cell count	13
can also cause	13
be differentiated from	13
may be considered	13
hbv dna was	13
in one of	13
for assessment of	13
increases in alt	13
impact on the	13
advanced fibrosis in	13
rather than the	13
inflammation of the	13
should be assessed	13
patients with low	13
central role in	13
is a significant	13
patients with or	13
in each group	13
but did not	13
in t dm	13
extrahepatic biliary tract	13
a central role	13
high risk of	13
be effective in	13
from the same	13
closure of the	13
extrahepatic portosystemic shunts	13
high prevalence of	13
as early as	13
may be necessary	13
patients with nash	13
patients with novel	13
and abdominal pain	13
kupffer cells and	13
with hcv genotype	13
of hepatic copper	13
all patients had	13
levels of alt	13
to be of	13
length of hospital	13
proved to be	13
that are not	13
donation after circulatory	13
a high mortality	13
intestinal bacterial overgrowth	13
activity in the	13
pancreatitis in cats	13
the liver to	13
time of diagnosis	13
hepatic steatosis in	13
mortality rate of	13
liver failure acute	13
coronavirus disease in	13
days of age	13
have been developed	13
mg kg orally	13
weeks of therapy	13
bile acids are	13
does not appear	13
the performance of	13
cause of acute	13
hcc cell lines	13
revealed that the	13
the state of	13
transplantation in patients	13
of foals with	13
of liver cancer	13
in individuals with	13
was induced by	13
young dogs and	13
the quality of	13
development of hcc	13
is not uncommon	13
be detected in	13
summarized in table	13
vitamin a deficiency	13
in hepatocytes and	13
time of the	13
significantly lower in	13
negative chronic hepatitis	13
can only be	13
expression levels of	13
as the liver	13
the first year	13
the combination treatment	13
of the kidney	13
is higher in	13
of the high	13
of fibrosis in	13
was analyzed by	13
nonalcoholic steatohepatitis in	13
hbv infection and	13
of hepatic dysfunction	13
observed in patients	13
a small number	13
and patient survival	13
in the regulation	13
reported to have	13
in patients receiving	13
of treatment and	13
mean arterial pressure	13
at week and	13
hepatic failure in	13
liver disease may	13
are found in	13
portal vein hypoplasia	13
clinical signs include	13
the condition of	13
with acute respiratory	13
one or more	13
large amounts of	13
the mechanisms of	13
results indicate that	13
than those of	13
in these cases	13
the value of	13
have the potential	13
a pilot study	13
there was an	12
could be used	12
a license to	12
characterized by a	12
is converted to	12
serum hcv rna	12
commonly used in	12
with advanced fibrosis	12
ventilation blood flow	12
therapy may be	12
the preprint in	12
occur in patients	12
and protein expression	12
sarcopenia in lc	12
occurs in the	12
with congenital portosystemic	12
in the small	12
some degree of	12
the stomach and	12
based on a	12
one study of	12
insulin resistance in	12
have a higher	12
hbv dna copies	12
in more detail	12
dogs with portosystemic	12
and of patients	12
could be a	12
weeks after the	12
year of age	12
cirrhosis due to	12
has been recommended	12
of portal vein	12
of lopinavir ritonavir	12
was found between	12
the finding of	12
to achieve a	12
of choice for	12
the hepatorenal syndrome	12
approved by the	12
to display the	12
novel coronavirus disease	12
liver transplantation using	12
higher in patients	12
the esophagus is	12
causes of acute	12
is well known	12
the definition of	12
this preprint this	12
well as to	12
the disease is	12
liver disease or	12
of the above	12
diagnosis of liver	12
hepatic insulin resistance	12
patients were followed	12
and the results	12
the usefulness of	12
mean age was	12
stem cells in	12
followed by a	12
underlying cause of	12
placed in the	12
cholestatic liver disease	12
in the peripheral	12
signs of abdominal	12
levels were measured	12
liver function is	12
of patients and	12
this version posted	12
plasminogen activator inhibitor	12
by liver biopsy	12
been used for	12
year survival rate	12
associated with significant	12
an attempt to	12
was related to	12
activity may be	12
liver biopsy and	12
adsorbent recirculating system	12
of ascites in	12
can affect the	12
be performed to	12
study was performed	12
serum liver enzyme	12
for this purpose	12
the operating room	12
right upper quadrant	12
patients with different	12
between the groups	12
at that time	12
can be treated	12
for this preprint	12
preprint in perpetuity	12
functions of the	12
protein in the	12
for hepatic encephalopathy	12
fibrosis and cirrhosis	12
activated protein kinase	12
liver disease as	12
refers to the	12
molecular adsorbent recirculating	12
of a novel	12
with the same	12
critically ill group	12
in serum and	12
portal venous blood	12
was assessed by	12
were analyzed by	12
of the lungs	12
it was found	12
these data suggest	12
up to days	12
infection of the	12
are able to	12
hbv dna in	12
hepatic failure and	12
american association for	12
patients with viral	12
congenital hepatic fibrosis	12
the emergence of	12
patients with end	12
confirm the diagnosis	12
so as to	12
acute on chronic	12
were infected with	12
hcc cell line	12
the patient was	12
with evidence of	12
a randomized trial	12
who has granted	12
may be of	12
of critically ill	12
weeks of age	12
results of the	12
herpes simplex virus	12
the conversion of	12
to the icu	12
induced acute liver	12
higher in severe	12
license to display	12
the concept of	12
described in cats	12
mechanism of liver	12
of the hcv	12
hepatic enzyme activities	12
in hbeag positive	12
in the usa	12
the author funder	12
it is usually	12
kidney and liver	12
copyright holder for	12
a part of	12
dynamic changes of	12
with fulminant liver	12
that it is	12
for liver failure	12
did not change	12
and bile duct	12
the cell cycle	12
be an important	12
for weeks and	12
aim was to	12
of hepatic injury	12
produced in the	12
function in the	12
if there are	12
result in the	12
as a risk	12
in people with	12
a is the	12
in this population	12
which is the	12
in the human	12
western blot analysis	12
adverse events were	12
majority of the	12
liver disease the	12
display the preprint	12
without liver injury	12
the american association	12
is the author	12
were as follows	12
death in patients	12
among the three	12
we performed a	12
medrxiv a license	12
is commonly used	12
preprint this version	12
or chronic liver	12
is dependent on	12
partial pressure of	12
compared to non	12
at this time	12
in foals with	12
b e antigen	12
dna copies ml	12
response in the	12
the range of	12
to chronic liver	12
cerebral blood flow	12
portal hypertension in	12
in group ii	12
in the feces	12
the utility of	12
is also possible	12
the pathology of	12
in the critically	12
protein expressions of	12
hepatitis c and	12
and kupffer cells	12
in healthy cats	12
of the hepatocytes	12
compared to healthy	12
failure induced by	12
plasma levels of	12
to maintain the	12
in north america	12
and t dm	12
to the hepatic	12
patients with sars	12
in approximately of	12
improvement in liver	12
of acute hepatic	12
t cells and	12
in de eerste	12
and inhibition of	12
a liver transplant	12
expression of a	12
clinical signs in	12
absorbed from the	12
study on the	12
also been reported	12
version posted june	12
in the lungs	12
in our previous	12
significantly correlated with	12
and liver dysfunction	12
in the pathophysiology	12
that the liver	12
than in sc	12
by a novel	12
upper gastrointestinal bleeding	12
signs of hepatic	12
disease should be	12
by vitamin k	12
has granted medrxiv	12
was performed to	12
can be classified	12
in this group	12
in portal hypertension	12
were classified as	12
outcomes of covid	12
presence of a	12
patients suffering from	12
no more than	12
may cause liver	12
holder for this	12
is found in	12
chb patients with	12
granted medrxiv a	12
the portal venous	12
in this case	12
in the post	12
of infection and	12
hepatitis b in	12
this work was	12
portosystemic vascular anomalies	12
hepatic lipidosis in	12
to have an	11
not yet been	11
hepatic nodular hyperplasia	11
from january to	11
accumulation in the	11
bile ducts and	11
surface of the	11
causes of liver	11
liver transplantation has	11
and lack of	11
is essential to	11
males and females	11
high incidence of	11
the changes of	11
within the first	11
to enhance the	11
at the university	11
patients in group	11
infectious diseases of	11
in alt activity	11
on patients with	11
are the major	11
with the highest	11
of renal function	11
graft and patient	11
to analyze the	11
license it is	11
with decompensated liver	11
treated with a	11
total number of	11
were reported in	11
to portal hypertension	11
weeks of treatment	11
and has a	11
higher in group	11
virus infection in	11
is recommended for	11
positive predictive value	11
egf transgenic mice	11
cells and the	11
was achieved in	11
and quality of	11
part of a	11
decompensated liver cirrhosis	11
side of the	11
should only be	11
without t dm	11
results showed that	11
is that the	11
renal blood flow	11
and cirrhosis in	11
of the ivc	11
of which were	11
dependent on the	11
the likelihood of	11
the results showed	11
symptoms and signs	11
risk of infection	11
under a is	11
intestinal small cell	11
renal function in	11
hcv rna positive	11
white blood cell	11
sensitive and specific	11
liver disease are	11
shunting in dogs	11
than in dogs	11
complete blood count	11
studies on the	11
melter et al	11
and is the	11
associated with poor	11
international license it	11
correlation with the	11
congenital pancreatic hypoplasia	11
that may be	11
failure in the	11
between january and	11
after treatment with	11
serum hepatic enzyme	11
hbv dna load	11
in the near	11
such as a	11
been treated with	11
liver function test	11
improvement of the	11
dilation of the	11
infected with novel	11
than those with	11
the united kingdom	11
it is made	11
survival rate of	11
dst and anti	11
patients who received	11
it is well	11
obtained from the	11
change in the	11
therapy in the	11
one of these	11
in the gallbladder	11
into the portal	11
serum alt and	11
has been identified	11
development and progression	11
than of the	11
older than years	11
in a group	11
histopathologic examination of	11
mouse model of	11
was significantly lower	11
phase ii clinical	11
mortality in patients	11
to liver injury	11
evaluate the efficacy	11
the clinical and	11
adult patients with	11
induced hepatic injury	11
be achieved by	11
can be difficult	11
in liver and	11
an assessment of	11
the foreign body	11
positive and negative	11
a week for	11
copies ml and	11
in hbeag negative	11
is a potential	11
resulting in increased	11
were similar in	11
result in a	11
does not necessarily	11
associated with clinical	11
in a few	11
two of the	11
of vitamin k	11
with portosystemic shunts	11
patients who died	11
increased hepatic copper	11
be required to	11
thickening of the	11
indicate that the	11
inhibitory effect on	11
of the organism	11
patient with liver	11
along with the	11
clinical outcomes in	11
of the canine	11
the urea cycle	11
patients were randomized	11
in the initial	11
they may be	11
the patients who	11
egf induced liver	11
portal vein is	11
for those patients	11
disease severity and	11
such as anorexia	11
an analysis of	11
disease in patients	11
the kidney and	11
a higher risk	11
of the gm	11
to the formation	11
metabolized in the	11
such as il	11
the development and	11
an association between	11
combination with ribavirin	11
of serum alt	11
for the patients	11
meld score and	11
have been associated	11
features of patients	11
should be provided	11
higher levels of	11
the diagnostic criteria	11
response in patients	11
and mechanical ventilation	11
liver regeneration and	11
correlate with the	11
of cirrhosis and	11
a few days	11
basis of the	11
and efficacy of	11
may increase the	11
in the formation	11
in cirrhotic rats	11
that the levels	11
such as liver	11
clinical features and	11
and progression of	11
was to determine	11
liver injury were	11
patients that are	11
disease of the	11
history of liver	11
an animal model	11
were detected by	11
in this review	11
pcr and western	11
gene silencing in	11
oxidative stress in	11
was used as	11
is possible to	11
early detection of	11